Moderna’s bivalent COVID-19 booster increases antibodies by 15 times against Omicron subvariants; an Amazon virtual health clinic does not include health insurance and will vary in price depending on providers; some Omnipod 5 Automated Insulin Delivery System devices have issues with the charging port and cable.
Moderna announced its updated COVID-19 booster increases antibodies against Omicron subvariants, The Washington Post reported. Among patients who received the new bivalent booster, Omicron-blocking antibody levels were 15 times higher compared with levels prior to received the booster. These findings are not yet peer reviewed, but are similar to results of a small study of Pfizer/BioNTech’s bivalent COVID-19 booster. Moderna added that a small preliminary analysis showed antibodies from the booster lost some potency against the growing BQ.1.1 subvariant—which makes up about a quarter of US COVID-19 cases—but could still block it.
Amazon today launched Amazon Clinic, a virtual health care platform where users can connect with providers to help treat common ailments such as allergies and skin conditions, Reuters reported. The service will operate in 32 states, does not include health insurance, and will vary in price depending on providers. Amazon piloted virtual health care visits for its staff in Seattle in 2019 before expanding to other employers under the Amazon Care brand, which is set to close down by the end of 2022. Amazon is also still working to close its $3.49 billion deal to buy One Medical to expand its virtual health care presence and add brick-and-mortar doctors’ offices.
Insulet Corporation announced a nationwide voluntary Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System due to an issue with the device’s charging port and cable. According to a news release, Insulet has received 24 reports of charging cables or ports melting, deforming, or discoloring due to heat generated by a poor connection between the cable and the port, which may also cause burns or fires. Insulet said this issue does not affect the Omnipod 5 Pod, Omnipod DASH Insulin Management System, Omnipod Insulin Management System, or compatible Android smartphone devices with the Omnipod 5 App installed.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More